Article History

Accepted: 23 November 2023

First Online: 26 December 2023

Change Date: 24 April 2025

Change Type: Correction

Change Details: A Correction to this paper has been published:

Change Details: https://doi.org/10.1007/s11469-025-01482-6

Change Date: 22 January 2024

Change Type: Correction

Change Details: A Correction to this paper has been published:

Change Details: https://doi.org/10.1007/s11469-024-01242-y

Declarations

:

: The authors declare no competing interests.

: Ethical approval was obtained on 20 May 2021 from the Ethical Board of the Czech National Monitoring Centre for Drugs and Addictions, Prague, Czechia, for all participating countries. In some countries additional local approval was required: 1) For Spain, approval was obtained on 23 July 2021 from the “Comité de Ética de la Investigación con medicamentos del Parc de Salut MAR”, Barcelona, Spain. 2) For Switzerland, on 17 December 2021 the Swiss Kantonale Ethikkommission in Zurich reviewed the protocol and decided the study was exempt from ethical approval (due to only asking opinions). 3) For Cyprus, on 31 January 2022 ethical approval was obtained. 4) For Canada, on 1 February 2022 also ethical approval was obtained. For further details and original documents seeAnnex 2 in the online appendix, section 2.17 "Ethical Approvals"